{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:06:19Z","timestamp":1790111179575,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofcardiovascularct.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Computed Tomography"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jcct.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:56:58Z","timestamp":1728097018000},"page":"74-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reproducibility of myocardial extracellular volume quantification using dual-energy computed tomography in patients with cardiac amyloidosis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-2219","authenticated-orcid":false,"given":"Yoshito","family":"Kadoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2995-8792","authenticated-orcid":false,"given":"Mehmet Onur","family":"Omaygenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcct.2024.09.011_bib1","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcct.2024.09.011_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jcct.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/ehjci\/jead137","article-title":"The role of imaging in the selection of patients for HFpEF therapy","volume":"24","author":"Baron","year":"2023","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.jcct.2024.09.011_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcct.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcct.2024.09.011_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcct.2024.09.011_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcct.2024.09.011_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcct.2024.09.011_bib9","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcct.2024.09.011_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12350-019-01761-5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization","volume":"27","author":"Dorbala","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcct.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehr481","article-title":"Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology","volume":"330","author":"Ugander","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcct.2024.09.011_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcct.2024.09.011_bib13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1148\/radiol.12112458","article-title":"Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT","volume":"264","author":"Nacif","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jcct.2024.09.011_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1148\/radiol.13130130","article-title":"Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings","volume":"269","author":"Bandula","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jcct.2024.09.011_bib15","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jcmg.2020.05.029","article-title":"Identifying cardiac amyloid in aortic stenosis: ECV quantification by CT in TAVR patients","volume":"13","author":"Scully","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcct.2024.09.011_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12410-021-09560-8","article-title":"Cardiac computed tomography for amyloidosis","volume":"14","author":"Small","year":"2021","journal-title":"Current Cardiovascular Imaging Reports"},{"key":"10.1016\/j.jcct.2024.09.011_bib17","article-title":"Dual versus single energy cardiac CT to measure extra cellular volume in cardiac amyloidosis: correlations with cardiac MRI","volume":"44","author":"Tavoosi","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jcct.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1007\/s00330-023-09872-x","article-title":"CT for the evaluation of myocardial extracellular volume with MRI as reference: a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jcct.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jcmg.2023.03.021","article-title":"Cardiac computed tomography for quantification of myocardial extracellular volume fraction: a systematic review and meta-analysis","volume":"16","author":"Han","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcct.2024.09.011_bib20","doi-asserted-by":"crossref","DOI":"10.1118\/1.4819936","article-title":"A\u00a0framework to measure myocardial extracellular volume fraction using dual-phase low dose CT images","volume":"40","author":"Liu","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.jcct.2024.09.011_bib21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.dib.2016.03.073","article-title":"Data on correlation between CT-derived and MRI-derived myocardial extracellular volume","volume":"7","author":"Kurita","year":"2016","journal-title":"Data Brief"},{"key":"10.1016\/j.jcct.2024.09.011_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2016151289","article-title":"Myocardial extracellular volume fraction with dual-energy equilibrium contrast-enhanced cardiac CT in nonischemic cardiomyopathy: a prospective comparison with cardiac mr imaging","volume":"280","author":"Lee","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jcct.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jcct.2015.07.001","article-title":"Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis","volume":"9","author":"Treibel","year":"2015","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcct.2024.09.011_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2018.05.027","article-title":"Extracellular volume quantitation using dual-energy CT in patients with heart failure: comparison with 3T cardiac MR","volume":"268","author":"Wang","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcct.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcct.2024.09.011_bib27","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcct.2024.09.011_bib28","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"ATTR-ACT study investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcct.2024.09.011_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ejhf.2027","article-title":"Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study","volume":"23","author":"Damy","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcct.2024.09.011_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of Cardiovascular Computed Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934592524004453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934592524004453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T01:03:12Z","timestamp":1750294992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934592524004453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1934592524004453"],"URL":"https:\/\/doi.org\/10.1016\/j.jcct.2024.09.011","relation":{},"ISSN":["1934-5925"],"issn-type":[{"value":"1934-5925","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproducibility of myocardial extracellular volume quantification using dual-energy computed tomography in patients with cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Computed Tomography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcct.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Society of Cardiovascular Computed Tomography\u00e9","name":"copyright","label":"Copyright"}]}}